feed,title,long_url,short_url
Benzinga,HUMIRAÂ® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis,https://benzinga.com/pressreleases/21/02/n19843623/humira-adalimumab-receives-fda-approval-to-treat-pediatric-patients-living-with-moderately-to-seve,
Benzinga,Aeromexico receives the Third and Final Disbursement under the DIP Financing,https://benzinga.com/pressreleases/21/02/n19843590/aeromexico-receives-the-third-and-final-disbursement-under-the-dip-financing,
Benzinga,CHS Board announces Retirement of CEO Joseph M. Catania,https://benzinga.com/pressreleases/21/02/n19843587/chs-board-announces-retirement-of-ceo-joseph-m-catania,
Benzinga,EasyDMARC Expands Its Presence in Americas by Appointing Rob Bowker as a Director Sales North America,https://benzinga.com/pressreleases/21/02/n19843583/easydmarc-expands-its-presence-in-americas-by-appointing-rob-bowker-as-a-director-sales-north-amer,
